- Research works
- 29 ▼ 52% vs 2018-21
- Citations
- 1.1k 37.9 per fractional work
- Top-10% rate
- 9.0% all institutions 10.0%
- Open access
- 41% world 40%
- International
- 13% world 18%
Not ranked overall: Amine Pharma (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Amine Pharma (Japan) work in?
In all years, 69% of research at Amine Pharma (Japan) is in Life Sciences, 24% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (60%), Medicine (23%), Neuroscience (4%). It does 3.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Life Sciences2069.3%
- Health Sciences723.8%
- Physical Sciences26.7%
- Environmental Science13.8%
- Chemistry12.0%
- Engineering00.4%
- Physics and Astronomy00.3%
- Materials Science00.2%
- Social Sciences00.2%
- Psychology00.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 13.6×. Every wedge is a field page.
All 7 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology13.56×2 works
- Pharmacology, Toxicology and Pharmaceutics9.16×0 works
- Nursing4.94×0 works
- Neuroscience1.99×0 works
- Immunology and Microbiology1.60×0 works
- Agricultural and Biological Sciences0.97×0 works
- Medicine0.65×0 works
Which keywords describe research at Amine Pharma (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Metabolism, Aging, Plant Development, Autophagy, Biogenic Amines, Polyamines and Metabolic Disorders.
- Ecology
- Endocannabinoid System
- Genomics
- Neurological Disorders
- Oxidative Stress
- D-Serine
- Schizophrenia
- Metabolic Disorders
- Biogenic Amines
- Plant Development
- Aging
- Cancer
- Metabolism
- Autophagy
- Polyamines
- Inflammation
- Amino Acid Transporters
- Neuronal Function
- Neuroprotection
- Antioxidant
- Cannabinoid Receptors
- Mitochondrial Function
- Virus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Cancer11▲ 28×8 topics
- Aging7▲ 49×4 topics
- Metabolism7▲ 40×8 topics
- Plant Development7▲ 266×2 topics
- Autophagy7▲ 408×2 topics
- Biogenic Amines7▲ 380×1 topic
- Polyamines7▲ 815×1 topic
- Metabolic Disorders6▲ 105×3 topics
- Inflammation4▲ 6.3×27 topics
- Schizophrenia4▲ 107×2 topics
- Amino Acid Transporters4▲ 330×1 topic
- D-Serine4▲ 330×1 topic
- Neuronal Function4▲ 119×2 topics
- Oxidative Stress3▲ 6.0×19 topics
- Neuroprotection2▲ 20×5 topics
- Neurological Disorders2▲ 9.7×3 topics
- Antioxidant2▲ 8.3×6 topics
- Genomics2▲ 16×3 topics
- Cannabinoid Receptors2▲ 183×1 topic
- Endocannabinoid System2▲ 183×1 topic
- Mitochondrial Function1▲ 26×4 topics
- Ecology1▲ 19×1 topic
- Virus1▲ 32×1 topic
Which research topics does Amine Pharma (Japan) publish most on?
By volume in 2022-now: Polyamine Metabolism and Applications, Amino Acid Enzymes and Metabolism, Muscle metabolism and nutrition and Aldose Reductase and Taurine.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Polyamine Metabolism and Applications Molecular Biology 1 works
- 2 Amino Acid Enzymes and Metabolism Biochemistry 1 works
- 3 Muscle metabolism and nutrition Cell Biology 0 works
- 4 Aldose Reductase and Taurine Cell Biology 0 works
- 5 Phytochemicals and Antioxidant Activities Biochemistry 0 works
- 6 Pharmacological Effects of Natural Compounds Pharmacology 0 works
- 7 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
- 8 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 10 Ion Channels and Receptors Sensory Systems 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Amine Pharma (Japan)'s research output changed?
Output in 2022-2025 was 52% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Amine Pharma (Japan) as a percentage of every work published that year, 0.0000025% in 2024.
Fractional works of Amine Pharma (Japan) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Chiba
- Chiba University
- Tokyo Dental College
- National Institutes for Quantum Science and Technology
- Tokyo University of Information Sciences
- Chiba Cancer Center
- Zen-Noh (Japan)
- The Open University of Japan
- Tokyo Dental College Ichikawa General Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Amine Pharma (Japan). Posts are plain text and can be reported.